-
COMPARING TEST-RETEST RELIABILITY AND RESPONSIVENESS OF EQ-5D-5L WITH FOUR BOLT-ONS, PROMIS-29 AND SKINDEX-16 IN PSORIASIS AND ATOPIC DERMATITIS PATIENTS
Mar 18, 2026, 21:38 PM -
EVALUATING THE PATIENT BURDEN ASSOCIATED WITH DELAYED REIMBURSEMENT: A CASE STUDY OF PEMBROLIZUMAB IN THE TREATMENT OF ENDOMETRIAL CANCER IN CANADA
Mar 18, 2026, 21:38 PM -
FORECASTING CLINICAL OUTCOMES FROM LIMITED REAL-WORLD DATA: A COMPARATIVE SIMULATION STUDY
Mar 18, 2026, 21:38 PM -
RECEIPT OF SARS-COV2 MRNA VACCINE PRIOR TO IMMUNE CHECKPOINT INHIBITOR THERAPY ASSOCIATED WITH SIGNIFICANTLY IMPROVED OVERALL SURVIVAL ACROSS MULTIPLE METASTATIC CANCERS: RESULTS FROM A REAL-WORLD EVIDENCE STUDY
Mar 18, 2026, 21:38 PM -
CLINICAL BENEFITS OF NIRMATRELVIR/RITONAVIR TREATMENT FOR COVID-19: A GLOBAL ECONOMIC VALUE SYSTEMATIC LITERATURE REVIEW
Mar 18, 2026, 21:38 PM -
PSYCHOLOGICAL AND COMPETITIVE DETERMINANTS OF LOW BACK PAIN KNOWLEDGE AMONG COMPETITIVE ROWERS
Mar 18, 2026, 21:38 PM -
CLINICAL OUTCOMES AND ECONOMIC BURDEN FOLLOWING TREATMENT FOR UNRESECTABLE OR METASTATIC ESOPHAGEAL CANCER
Mar 18, 2026, 21:38 PM -
A SYSTEMATIC REVIEW OF ONCOLYTIC VIRUSES AND GENE THERAPIES FOR RETINOBLASTOMA IN CHILDREN
Mar 18, 2026, 21:38 PM -
TRENDS AND ANNUALIZED CHANGES IN HUMAN PAPILLOMAVIRUS (HPV) VACCINATION AMONG ADOLESCENTS IN THE UNITED STATES, 2013-2023
Mar 18, 2026, 21:38 PM -
THE ECONOMIC IMPACT OF PERIOPERATIVE IMMUNE CHECKPOINT INHIBITORS IN RESECTABLE GASTRIC AND GASTROESOPHAGEAL JUNCTION CANCERS IN A CANADIAN SETTING
Mar 18, 2026, 21:38 PM -
REAL-WORLD TRANSITION PROBABILITY ANALYSES AMONG UNRESECTABLE LOCALLY ADVANCED (LA) ESOPHAGEAL/GASTROESOPHAGEAL JUNCTION CANCER (EC/GEJC) PATIENTS TREATED WITH DEFINITIVE CHEMORADIOTHERAPY (DCRT) AT COMMUNITY ONCOLOGY CENTERS
Mar 18, 2026, 21:38 PM -
AN ONTOLOGY-INFORMED STRATEGY FOR MEDICATION INTEROPERABILITY IN REAL-WORLD DATA: FROM ANALYTIC FEASIBILITY TO CONCEPTUAL FOUNDATIONS
Mar 18, 2026, 21:38 PM -
INDIRECT TREATMENT COMPARISONS IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA: INSIGHTS FROM RECENT NICE SUBMISSIONS
Mar 18, 2026, 21:38 PM -
REAL-WORLD USE OF BIOLOGICS IN CROHN’S DISEASE: ALIGNMENT WITH HEALTH PLAN COVERAGE REQUIREMENTS
Mar 18, 2026, 21:38 PM -
ECONOMIC EVALUATION OF TARGETED PERINATAL DEPRESSION SCREENING FOR HIGH-RISK WOMEN IN CHINA
Mar 18, 2026, 21:38 PM -
FACTORS ASSOCIATED WITH TREATMENT ENGAGEMENT AMONG EMERGENCY DEPARTMENT PATIENTS WITH OPIOID USE DISORDER AFTER DISCHARGE: A RETROSPECTIVE COHORT STUDY
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERN IN PATIENTS WITH ADVANCED BREAST CANCER AFTER CDK4/6I FAILURE IN CHINA
Mar 18, 2026, 21:38 PM -
ACCESS TO ESSENTIAL BREAST AND CERVICAL CANCER MEDICINES IN NIGERIA: A WHO/HAI-BASED EVALUATION OF PRICES, AVAILABILITY, AND AFFORDABILITY
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF LATENT TUBERCULOSIS INFECTION INTERVENTIONS IMPLEMENTED DURING THE TUBERCULOSIS EPIDEMIOLOGIC STUDIES CONSORTIUM (TBESC-III)
Mar 18, 2026, 21:38 PM -
APPLYING THE POMELO BEST PRACTICES FRAMEWORK TO ENHANCE REPORTING STANDARDS IN PATIENT LISTENING STUDIES FROM SOCIAL MEDIA
Mar 18, 2026, 21:38 PM
